Ipca Laboratories on Wednesday reported 67% increase in consolidated net profit at Rs 180 crore for the third quarter ended Dec. 31, 2023.
The drugmaker had reported a net profit of Rs 108 crore for October-December FY23.
Revenue from operations rose to Rs 2,053 crore from Rs 1,546 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading 0.86% down at Rs 1,150.15 apiece on the BSE.
ADVERTISEMENT
RECOMMENDED FOR YOU

IRB Infrastructure Q1 Results: Net Profit Rises 45% To Rs 202 Crore


Hindustan Copper Q1 Results: Profit Down 29%


Bajaj Consumer Care, Bata, IPCA Laboratories, Astral Q1 Results Today — Earnings Estimates


Who Is Mira Murati? Ex-OpenAI CTO's Team Rejects $1 Billion Job Offer From Meta
